'Suicide cell' plan to beat breast cancer
Monday 30 May 1994
The method centres on a new approach to cancer gene therapy being devised by a team at the Imperial Cancer Research Fund, which has worked out a way of tricking a breast tumour cell into activating a drug that will kill it.
The scientists from the charity's cancer unit at London's Hammersmith Hospital have asked for approval to start trials with 10 volunteer patients with advanced breast cancer. Dr Nick Lemoine, the team leader, said: 'This is the first time anyone has attempted to use a cancer gene to destroy a cancer cell.'
The method, published in the journal Gene Therapy, is called genetic prodrug activation therapy.
Breast cancer has been chosen for the trial because the team identified the molecular 'switch' controlling a gene called erbB-2 which is turned on in breast cancer cells but not in normal cells.
High levels of the protein produced by the gene are found in tumour cells in about a fifth of patients, whose outlook is very poor.
Dr Lemoine said: 'The first trial will not be an attempt to cure. It's fact-finding - checking whether we can make the cells activate the drug in the nodules.
'It works in the laboratory, but that is a long way from making it effective in patients.'
Diving in at the deep end is no excuse for shirking the style stakes
- 2 PornHub begs users to stop uploading video clips of Brazil getting beaten 7-1
- 3 Why I'm on the brink of burning my Israeli passport
- 4 L'Oreal cuts ties with Belgium supporter Axelle Despiegelaere after hunting trip photographs
- 5 The true Gaza back-story that the Israelis aren’t telling this week
Game of Thrones author George RR Martin says 'f*** you' to fans who fear he will die before finishing Westeros saga
Loom bands: Bids for dress made from colourful rubber pass £170,000 on eBay
Supermoon 2014: When and why will the moon look bigger and brighter this summer?
Gaza-Israel conflict: The terrible price children are paying for Israel’s war with Hamas
Rotten egg smell could help battle heart disease and Alzheimer's
Sustained immigration has not harmed Britons' employment, say government advisers
War is war: Why I stand with Israel
7/7 memorial defaced on anniversary of 2005 attacks with ‘Blair lied thousands died’ graffiti
Australia facing international condemnation after turning around Sri Lankans at sea
Even when it brutalises one of its own teenage citizens, America is helpless against Israel
Socialist Worker called to apologise over ‘vile’ article saying Eton schoolboy Horatio Chapple's death is ‘reason to save the polar bears’
£60000 - £80000 per annum + Benefits + Bonus: Harrington Starr: C# Integration...
£75000 - £85000 per annum + ex bens: Deerfoot IT Resources Limited: Biztalk Te...
£60000 per annum: Harrington Starr: Trade Desk Specialist (FIX, Linux, Windows...
£35000 per annum: Harrington Starr: Service Desk Analyst (Windows, Active Dire...